2,Alpha-DMT
From Wikipedia, the free encyclopedia
|
2,Alpha-DMT
|
|
| Systematic (IUPAC) name | |
| 1-(2-methyl-1H-indol-3-yl)propan-2-amine | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C12H16N2 |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
2,alpha-DMT, or 2,a-dimethyltryptamine, is a lesser-known psychedelic drug. It is the 2,a-dimethyl analog of DMT. 2,a-DMT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), Shulgin lists the dosage as 300-500 mg, and the duration as 7-10 hours.[1] 2,a-DMT causes mydriasis and tingling. It also produces a calm, drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,a-DMT.
[edit] References
- ^ Shulgin, Alexander; Ann Shulgin (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press, 422. ISBN 0-9630096-9-9. OCLC 38503252.
[edit] External links
|
|||||

